ABL1 and leukemia: Thus, while the median survival of mice with leukemia driven by BCR-ABL/∆HOXA9 was 26 days, the loss of RRM1 (BCR-ABL/∆RRM1) was 46 days, similar to BCR-ABL alone (43.5 days).